News Joint Grow Journal 79: Rosetta Stone XX (Part 2)
I’m back with Part 2 of my Rosetta Stone XX grow journal. I grew this strain because I am a fan of terpinolene-heavy strains and thought it might fit into our Work Sativa series.
Rosetta Stone XX is the all-female version of Rosetta Stone, bred by Brothers Grimm Seeds, and was rated “Top Ten of 2018” by High Times. The breeder pollinated his Jack Herer female with STS-induced Cinderella 99 female pollen. The resinous buds were long-oval-shaped and sticky.
Rosetta Stone XX’s aroma from the mason jar, as mentioned in Part 1, was terpinolene-lime forward with back notes of jasmine, incense, and sweet musk. As with most terpinolene-heavy strains I’ve grown, the longer the buds cured, the more pronounced the back notes became. As expected, the Rosetta Stone XX led with a heavy-terpinolene flavor of lime, anise, and sour incense. As with the aroma, the longer the cure the more pronounced the back notes. The lime and anise softened, and heavier notes of spicy citrus, earthy pine, sweet herbs, incense, musk, and wet wood came through.
The effects were strong with a quick onset. The cerebral head high was uplifting and energetic to start the buzz. A heavy headband effect hit the eyes and crown of the head. Despite the energetic nature, Rosetta Stone XX didn’t quite fit the Work Sativa profile because of the thought wandering and, with high doses, thoughtlock. The body buzz was stronger than expected. The body buzz started in the arms and worked its way to the body’s core, eventually delivering a floating sensation that eased muscle and joint pain. Instead of work, I mostly consumed Rosetta Stone XX while gaming, binge-watching television, socializing, and completing physical tasks. Rosetta Stone XX also boosted my appetite and had a slight crash at the very end of the buzz.
Visit here to read Part 1 of this grow journal. For more Illinois cannabis industry news, subscribe to Illinois News Joint’s newsletter here.
To find cannabis-friendly events in Illinois, visit here.
For Illinois News Joint reviews, visit here.
FDA Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from healthcare practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product.
Effects & Medical Attributes are based on anecdotal evidence. Individual experiences can be varied.




